Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
ClinicalTrials.gov study NCT01018069. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
ClinicalTrials.gov study NCT06372717. IPD Sharing: NO. Countries: 2. Publications: 0.
Prognostic Impacts of Lipid Profile and BMI in Adult AML
ClinicalTrials.gov study NCT07143877. IPD Sharing: NO. Countries: 1. Publications: 0.
Italian Non-Interventional Study of FLT3 Mutated AML Patients
ClinicalTrials.gov study NCT03547258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
ClinicalTrials.gov study NCT02124174. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00666497. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
ClinicalTrials.gov study NCT04168502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
ClinicalTrials.gov study NCT06329999. IPD Sharing: NO. Countries: 1. Publications: 0.
IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML
ClinicalTrials.gov study NCT06418776. IPD Sharing: NO. Countries: 1. Publications: 0.
Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05291390. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT01010373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Yea
ClinicalTrials.gov study NCT03257241. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN
ClinicalTrials.gov study NCT06690827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
ClinicalTrials.gov study NCT06565975. IPD Sharing: NO. Countries: 1. Publications: 0.
The Mutation Profile and Prognosis in AML With IDH1/2 Mutation
ClinicalTrials.gov study NCT07004816. IPD Sharing: NO. Countries: 1. Publications: 0.
PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
ClinicalTrials.gov study NCT00088231. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Geriatric Evaluations Impact on New AML Guidance
ClinicalTrials.gov study NCT05909501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT06180863. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML
ClinicalTrials.gov study NCT04220684. IPD Sharing: NO. Countries: 1. Publications: 0.
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03850418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.